Elitecon International Limited has received a penalty from BSE Limited for delayed submission of its quarterly financial results, according to a regulatory disclosure made on March 18, 2026.

Fine Details and Violation

The Bombay Stock Exchange imposed a fine of ₹1,12,100 on the company, which includes basic fine plus GST. The penalty was communicated through an email dated March 17, 2026, and relates to the late submission of unaudited financial results for the quarter and nine months ended December 31, 2025.

Regulatory Compliance Breach

The violation pertains to the company's failure to submit its unaudited financial results within the period prescribed under Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to submit their quarterly financial results within specified timelines to ensure transparency and timely disclosure to investors.

Company's Response and Impact Assessment

Elitecon International has acknowledged the fine and committed to making the payment within the timeline prescribed by the stock exchange. The company has assessed that there is no significant impact on its financial, operational, or other activities due to this penalty.

Regulatory Disclosure

The disclosure was made pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, which requires listed companies to inform stock exchanges about material events and developments. The company submitted the disclosure to both BSE Limited and The Calcutta Stock Exchange Ltd., providing complete details of the penalty as required under the regulatory framework.

The disclosure was signed by Vipin Sharma, Managing Director of the company, ensuring compliance with corporate governance requirements for such regulatory communications.

Elitecon International Limited has published its unaudited financial results for the quarter and nine months ended December 31, 2025, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company submitted copies of publication advertisements to stock exchanges on March 10, 2026, following the Board meeting held on March 07, 2026.

Regulatory Compliance and Publication

The company fulfilled its regulatory obligations under Regulation 30 read with Regulation 47 of SEBI LODR by publishing advertisements on March 10, 2026, in all editions of 'Financial Express' (English Language) and the Delhi Edition of 'Jansatta' (Hindi). These publications are also available on the company's website at www.eliteconinternational.com .

Standalone Financial Performance

The company's standalone operations demonstrated exceptional growth in Q3FY26. Revenue from operations increased substantially while maintaining strong profitability metrics despite challenging market conditions.

For the nine months ended December 31, 2025, standalone revenue reached ₹120,684.95 lakhs compared to ₹17,709.73 lakhs in the corresponding previous period. Net profit for the nine-month period stood at ₹5,012.02 lakhs versus ₹1,999.89 lakhs in the previous year.

Consolidated Results

The consolidated financial performance showed even stronger growth, reflecting the company's expanded operations through subsidiaries and strategic acquisitions.

The nine-month consolidated revenue reached ₹547,688.65 lakhs compared to ₹23,559.70 lakhs in the previous year, while consolidated net profit increased to ₹31,116.69 lakhs from ₹2,667.60 lakhs.

Segment Performance Analysis

Elitecon International operates through two primary business segments: Tobacco Products and FMCG Products. Both segments contributed significantly to the overall growth during the quarter.

Standalone Segment Results (Q3FY26)

Consolidated Segment Results (Q3FY26)

Corporate Actions and Strategic Developments

During the nine months ended December 31, 2025, the company completed a subdivision of its equity shares from ₹10 each to ₹1 each. The subdivision received member approval through an ordinary resolution passed on June 2, 2025, with necessary regulatory approvals obtained.

The company entered into Share Purchase Agreements dated September 4, 2025, for acquiring equity stakes in Sunbridge Agro Private Limited and Landsmill Agro Private Limited. While partial consideration has been discharged, the balance consideration was proposed to be funded through a Qualified Institutional Placement (QIP), which could not be concluded.

Regulatory and Legal Matters

Elitecon International continues to address several ongoing regulatory challenges:

GST Matters: The company is addressing a Show Cause Notice dated May 9, 2025, issued by the Directorate General of GST Intelligence (DGGI) regarding input tax credit for the period from October 2020 to October 2024. A personal hearing was attended on February 4, 2026, with no adjudication order passed yet.

FDA Inspection: Subsequent to the quarter end, officials from the Food and Drug Administration (FDA), Nashik, conducted inspections at the company's manufacturing facility on January 8, 2026, and at subsidiary Golden Cryo Private Limited on January 9, 2026. Certain tobacco product inventories and related machinery were seized during these inspections.

Legal Proceedings: The company is involved in legal proceedings with Advik Capital Limited, with matters pending before the High Court of Delhi and the National Company Law Tribunal (NCLT). The company is contesting these matters and taking appropriate legal steps.

Financial Position and Outlook

The company's paid-up equity share capital stands at ₹15,985.00 lakhs with a face value of ₹1 per share. The substantial revenue growth reflects the company's expanded operations and successful business diversification across tobacco and FMCG segments.

Management continues to evaluate the financial implications of regulatory actions and is working on resolving pending matters while maintaining normal business operations across other segments.